Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Huatai Minkang Biotechnology is a Chinese medical technology company focused on the development and commercialization of in vitro diagnostic (IVD) solutions. Specializing in molecular diagnostics, the company utilizes advanced PCR technologies to provide testing kits for infectious diseases, oncology, and genetic screening. Their product portfolio includes high-sensitivity kits for Human Papillomavirus (HPV) genotyping, respiratory pathogen detection, and personalized medicine markers such as MTHFR. Huatai Minkang operates from a state-of-the-art facility in Beijing, serving clinical laboratories and healthcare providers with integrated diagnostic instruments and reagents. The company is recognized as a high-tech enterprise and holds multiple NMPA certifications for its diagnostic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 华泰民康.